Gene · 5324
Papers4,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. | Theranostics | 2024 | 38250042 | PubTator, text mining | PubMed |
| Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy. | Clin Genitourin Cancer | 2024 | 38246830 | PubTator, text mining | PubMed |
| PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer. | Sci Rep | 2024 | 38245572 | PubTator, text mining | PubMed |
| Carcinosarcoma of the parotid gland: a case report and review of the literature. | J Med Case Rep | 2024 | 38243328 | PubTator, text mining | PubMed |
| New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium. | J Transl Med | 2024 | 38238739 | PubTator, text mining | PubMed |
| Impact of low pneumoperitoneum on renal function and acute kidney injury biomarkers during robot-assisted radical prostatectomy (RARP): a randomised clinical trial. | J Robot Surg | 2024 | 38231282 | PubTator, text mining | PubMed |
| Advances and Challenges in Nanomaterial-Based Electrochemical Immunosensors for Small Cell Lung Cancer Biomarker Neuron-Specific Enolase. | ACS Omega | 2024 | 38222505 | PubTator, text mining | PubMed |
| Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. | J Transl Med | 2024 | 38221616 | PubTator, text mining | PubMed |
| DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside. | J Transl Med | 2024 | 38212769 | PubTator, text mining | PubMed |
| The homologous tumor-derived-exosomes loaded with miR-1270 selectively enhanced the suppression effect for colorectal cancer cells. | Cancer Med | 2024 | 38197582 | PubTator, text mining | PubMed |
| Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer. | BMC Cancer | 2024 | 38191330 | PubTator, text mining | PubMed |
| Environmental aluminum oxide inducing neurodegeneration in human neurovascular unit with immunity. | Sci Rep | 2024 | 38185738 | PubTator, text mining | PubMed |
| Heteronormative biases and distinctive experiences with prostate cancer among men who have sex with men: a qualitative focus group study. | BMC Urol | 2024 | 38184578 | PubTator, text mining | PubMed |
| Trends in the incidence and survival of cancer in individuals aged 55 years and older in the United States, 1975-2019. | BMC Public Health | 2024 | 38172749 | PubTator, text mining | PubMed |
| Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer. | Exp Mol Med | 2024 | 38172600 | PubTator, text mining | PubMed |
| Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer. | J Cancer | 2024 | 38169514 | PubTator, text mining | PubMed |
| Quercetin stimulates trophoblast fusion via the mitochondrial function. | Sci Rep | 2024 | 38168580 | PubTator, text mining | PubMed |
| Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Silver-Russell Syndrome. | Int J Med Sci | 2024 | 38164354 | PubTator, text mining | PubMed |
| Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study. | Cancer Med | 2024 | 38140773 | PubTator, text mining | PubMed |
| Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications. | Pathol Res Pract | 2024 | 38056136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5324/papers?page=15